Position
Fidelity in Agomab Therapeutics Nv
Back to the book · All holders of AGMB
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $3.63M$10.49 → $12.98
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q1 2026 | 1.46M | $15.3M | — | — | — | 0.0% |
| Q2 2026 | 1.46M | $18.9M | $12.98 | $3.63M | $0 | 0.0% |